{"favorite_id": 2039, "calc_type": "", "dosing": false, "full_title_en": "SEDAN Score for Post-tPA Hemorrhage", "short_title_en": "SEDAN Score", "medium_description_en": "Predicts risk of Symptomatic Intracerebral Hemorrhage (sICH) after tPA.", "short_description_en": "Predicts sICH risk after tPA.", "before_use": "", "instructions_en": "<p>Applies to patients receiving tPA within 4.5 hours; does <strong>not</strong> apply to patients receiving endovascular treatment.</p>", "purpose_en": ["Prognosis"], "disease_en": ["Stroke/TIA"], "specialty_en": ["Critical Care", "Critical Care (Neurologic)", "Emergency Medicine", "Neurology"], "chief_complaint_en": ["Weakness"], "system_en": ["Neurologic"], "search_abbreviation_en": ["SEDAN", "Stroke", "CT scan", "blood sugar", "glucose", "hyperdense", "age", "NIHSS", "tpa"], "slug": "sedan-score-post-tpa-hemorrhage", "seo": {"meta_description_en": "The SEDAN score assesses symptomatic intracerebral hemorrhage (sICH) risk after thrombolysis.", "keywords_en": "SEDAN score, sedan score calc, sedan calc, sedan stroke calc, sedan stroke score, sedan s/p thrombolysis, sedan hemorrhage risk, sedan score hemorrhage risk, sedan prognosis, sedan mortality, stroke blood sugar score, stroke CT scan, density on CT sedan, density CT scan stroke calc, stroke calc CT scan, sedan nihss, sedan nih stroke score, sedan calculator sedan mdcalc, s/p thrombolysis calc, thrombolsysis calc sedan, s/p thrombolysis score sedan, s/p thrombolysis calc"}, "content": {"how_to_use": {"use_case_en": "<ul><li>Providing actual estimates of risk of tPA to patients and their family members.</li><li>Weighing risk of benefit and risk of harm in minor or severe strokes.</li></ul>", "pearls_pitfalls_en": "<ul><li>The SEDAN Score predicts risk of post-tPA hemorrhage.</li><li>tPA hemorrhage risk varies greatly, so its developers wanted to predict low- and high-risk patients.</li><li>The endpoint, \u201cSymptomatic Intracerebral Hemorrhage\u201d varies greatly from trial to trial depending on definition, making it difficult to compare outcomes.</li><li>The <calculator id='2030'>HAT Score</calculator> also predicts risk of <abbr title='Symptomatic Intracerebral Hemorrhage'>sICH</abbr> with fewer variables.</li><li>The <calculator id='1706'>THRIVE Score</calculator> predicts chance of good outcome after stroke (even without tPA) and does not require imaging variables.</li></ul><p><strong>Points to Consider</strong></p><ul><li>Patients in this score did not receive endovascular therapy.</li><li>sICH increases mortality dramatically.</li><li>tPA risks and benefits should be very clearly discussed and documented with patients and family members.</li></ul>", "why_use_en": "<p>With rates of <abbr title='Symptomatic Intracerebral Hemorrhage'>sICH</abbr> varying widely, the SEDAN Score can help predict which patients will be at low or high risk to go on to have sICH, which increases mortality dramatically.</p>"}, "next_steps": {"advice_en": "<ul> <li>Consider <calculator id='1934'>tPA contraindications</calculator> closely, as institutions may have slightly different definitions of contraindications (absolute and relative).</li> <li>tPA for stroke should only be given in conjunction with Neurology consultation and after extensive discussion with the patient and family about risk and benefit.</li> <li>Patients receiving tPA should be monitored in an ICU setting.</li> <li>Even in low-risk patients, patients with changing neurologic exams or mental status should receive emergent re-imaging to assess for sICH.</li> <li>Consider other bleeding sites (GI, GU, for example) in post-tPA patients and exercise caution with even minimally invasive procedures such as venipuncture or foley catheter placement.</li> </ul>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p>Addition of assigned points, as above.</p>", "more_info_en": "<p><strong>Score interpretation:</strong></p> <div class='table-responsive'> <table class='table table-bordered table-hover'> <tbody> <tr> <th>SEDAN Score</th> <th>Risk of Symptomatic ICH</th> </tr> <tr> <td>0</td> <td>1.6%</td> </tr> <tr> <td>1</td> <td>3.3%</td> </tr> <tr> <td>2</td> <td>5.4%</td> </tr> <tr> <td>3</td> <td>8.8%</td> </tr> <tr> <td>4</td> <td>12.3%</td> </tr> <tr> <td>5</td> <td>16.9%</td> </tr> </tbody> </table> </div>", "evidence_based_medicine_en": "<p><strong>Original Study</strong></p> <ul> <li>Developed in Europe</li> <li>Derived from 974 patients treated with tPA within 4.5 hours</li> <li>Basilar artery occlusion patients were not included in the study (but were separately evaluated later)</li> <li>Patients undergoing endovascular procedures for their stroke were also excluded from the study</li> <li>The ECASS-II definition of sICH was used: <ul> <li>An intracranial hemorrhage was defined as symptomatic if the patient had clinical deterioration causing an increase in the NIHSS score of more than or equal to 4 points and if the hemorrhage was likely to be the cause of the clinical deterioration. However, in case of doubt regarding whether edema or hemorrhage was the leading pathology, an association of the hemorrhage with the deterioration was assumed.</li> </ul> </li> <li>The score was then internally validated in 828 patients.</li> <li>Overall 7% of patients in the study developed sICH</li> </ul> <p><strong>External Validation</strong></p> <ul> <li>The SEDAN Score was validated in 34,251 patients</li> <li>In the validation study they used both the ECASS-II definition of sICH as well as the SITS-MOST definition of sICH: <ul> <li>Presence of parenchymal hemorrhage type 2 on CT with an NIHSS score increased by \u22654 points from baseline or the lowest NIHSS value after baseline to 24 hours</li> </ul> </li> <li>The SITS-MOST definition of sICH is more narrow than the ECASS-II definition, so many fewer patients will be defined as having sICH.</li> </ul>", "references_list": {"Original/Primary Reference": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/22522478", "text": "Strbian D, Engelter S, Michel P, Meretoja A, Sekoranja L, Ahlhelm FJ, Mustanoja S, Kuzmanovic I, Sairanen T, Forss N, Cordier M, Lyrer P, Kaste M, Tatlisumak T.Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol. 2012 May;71(5):634-41. doi: 10.1002/ana.23546."}], "Other References": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/25171393", "text": "Van Hooff RJ, et al. Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke.Clin Neurol Neurosurg. 2014 Oct;125:189-93. doi: 10.1016/j.clineuro.2014.08.011. Epub 2014 Aug 15."}], "Validation": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/23632975", "text": "Mazya MV, Bovi P, Castillo J, Jatuzis D, Kobayashi A, Wahlgren N, Ahmed N. External validation of the SEDAN score for prediction of intracerebral hemorrhage in stroke thrombolysis. Stroke. 2013 Jun;44(6):1595-600. doi: 10.1161/STROKEAHA.113.000794. Epub 2013 Apr 30."}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"description": "<p>Graham Walker, MD, is an emergency physician practicing in San Francisco, California. Dr. Walker attended medical school at the Stanford University School of Medicine and then trained in emergency medicine at St. Luke\u2019s-Roosevelt Hospital Center in New York City, where he was Chief Resident. He returned to the west coast as a Medical Simulation fellow and attending in Stanford\u2019s emergency department. More relevant, of course, is that Dr. Walker is the creator and developer of MDCalc and remains active in content and calculator development, along with our many other endeavors as President of MD Aware, LLC (MDCalc\u2019s parent company).</p>", "firstName": "Graham", "img": "https://cdn-web-img.mdcalc.com/people/graham-walker.jpg", "lastName": "Walker", "name": "Graham Walker, MD", "target": "graham-walker", "signedCOI": true, "hasDisclosure": []}]}, "creator": [{"name": "Dr. Daniel Strbian", "qa_en": "", "approved": true, "creator_info": {"about_en": " <p>Daniel Strbian, MD, PhD, is a practicing neurologist at the University of Helsinki Central Hospital in Finland. He is an active researcher in the field of ischemic stroke.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-daniel-strbian.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Strbian+D%5BAuthor%5D"}}], "reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Blood sugar", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "<145 mg/dL (8.1 mmol/L)", "value": 0}, {"label": "145-216 mg/dL (8.1\u201312.0 mmol/L)", "value": 1}, {"label": ">216 mg/dL (12.0 mmol/L)", "value": 2}], "name": "gluc"}, {"type": "toggle", "label_en": "Early infarct signs on initial CT", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Hypoattenuation comprising <1/3 of the middle cerebral artery territory; obscuration of the lentiform nucleus or Sylvian fissure; loss of basal ganglion outline or insular ribbon; cortical sulcal effacement", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "infarct"}, {"type": "toggle", "label_en": "Hyperdense cerebral artery sign on initial CT", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "ct"}, {"type": "toggle", "label_en": "Age > 75 years", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "age"}, {"type": "toggle", "label_en": "<calculator id='715'>NIH Stroke Scale (NIHSS)</calculator> \u2265 10", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "nihss"}], "md5": "", "cmeVersion": "2039.1", "related_calcs": [{"calcId": 2030, "short_title_en": "HAT Score", "slug": "hat-hemorrhage-thrombolysis-score-predicting-post-tpa-hemorrhage"}, {"calcId": 715, "short_title_en": "NIH Stroke Scale (NIHSS)", "slug": "nih-stroke-scale-score-nihss"}, {"calcId": 1706, "short_title_en": "THRIVE Score", "slug": "thrive-score-stroke-outcome"}]}